Published on : Dec 20, 2016
ALBANY, NY, Dec 20, 2016: The publication predicts the rise of the global coronary stents market at a 3.05% CAGR for the forecast period 2016–2021, with the upsurge accounted to an increase in cardiovascular diseases and lifestyle related diseases, such as obesity, diabetes, and hypertension.
After conducting surveys as part of their primary research, research analysts have exploited the value chain of the global coronary stents market to procure decisive insights from industry experts, stakeholders, and companies. With secondary research and quantitative as well as qualitative research, the analysts have been able to put down key market determinants, such as aggressive landscapes, market size, latest trends and developments, and market segmentation.
According to the report, the global coronary stents market can be segmented on the basis of three parameters, viz. segment or type, region, and country.
On the basis of segment, bioresorbable stents are prophesied to witness colossal growth in the international market during the forecast period. The demand for bioresorbable stents mainly stems from its growing compatibility and technological innovation through clinical trials. Within a short span of only two to three years, this promising stent type bears the ability to dissolve completely in the body. Another reason for the increasing number of stent procedures being implemented using bioresorbable stents is the much needed approval from the U.S. Food and Drug Administration (FDA).
Click to get more details with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=895850
Drug-eluting stents (DES) are expected to maintain stability in the market even after receiving resistance over the years for being a highly dominant segment. They help avoid re-stenting and reduce or delay the need for restenosis with its specialized drug constituent.
Although they are priced economically and provide an alternative for patients disqualified for DES, bare metal stents are still prominent. However, their demand is predicted to decline severely due to high rate of restenosis, side effects such as inflammation, and adoption of other stent types.
The global coronary stents market report provides geographical coverage, considering North America, Europe, APAC, and ROW, and segmentation by country, which includes the U.S., Canada, the U.K., Germany, India, Japan, China, Brazil, and UAE. With rising awareness about cardiovascular diseases, especially among the middle-income population, and continuing focus on developing healthcare infrastructure, the global market is foretold to receive a positive response from emerging nations. With regard to revenue, developed regions will continue to account for the lion’s share in the market. While APAC and ROW are likely to demonstrate robust growth in the market, the report foresees North America and Europe to remain major markets over the forecast period.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]